Robert S. Pritchard, MD

Martha Jefferson Hospital Cancer Care ...Charlottesville, Virginia - 22901 (434-982-8390) |
- CLINICAL TRIALS 6
- CONDITIONS16
- INTERVENTIONS27
- SINCE2005

Zoledronic Acid in Treating Patients With Metastatic Breast Cancer Metastatic Prostate Cancer or Multiple Myeloma With Bone Involvement
March 2009 - May 2015

Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
April 2008 - January 2010

Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I Stage II or Stage III Non-Small Cell Lung Cancer
October 2005 - February 2008

Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
May 2008 - February 2009

Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
November 2005 - June 2008

Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB Stage II or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
June 2007 - July 2015
Breast Neoplasms
Colonic Neoplasms
Lung Neoplasms
Adenocarcinoma
Prostatic Neoplasms
Multiple Myeloma
Neoplasms, Plasma Cell
Neoplasms
Neoplasm Metastasis
Carcinoma, Non-Small-Cell Lung
Neurotoxicity Syndromes
Colorectal Neoplasms
Peripheral Nervous System Diseases
Demyelinating Diseases
Polyneuropathies
Neurologic Manifestations
Placebo
Immunohistochemistry Staining Method
Laboratory Biomarker Analysis
Zoledronic Acid
Study Of Socioeconomic And Demographic Variables
Bevacizumab
Cisplatin
Docetaxel
Fluorouracil
Leucovorin Calcium
Gemcitabine Hydrochloride
Gene Expression Analysis
Polymorphism Analysis
Pemetrexed Disodium
Oxaliplatin
Polymerase Chain Reaction
Mutation Analysis
Cetuximab
Study Of High Risk Factors
Matrix-Assisted Laser Desorption/Ionization Time Of Flight Mass Spectrometry
Tamoxifen Citrate
Irinotecan Hydrochloride
Letrozole
Duloxetine Hydrochloride
Vinorelbine Ditartrate
Chromogenic In Situ Hybridization
Fluorescent Antibody Technique



